calpain and Central-Nervous-System-Diseases

calpain has been researched along with Central-Nervous-System-Diseases* in 3 studies

Reviews

3 review(s) available for calpain and Central-Nervous-System-Diseases

ArticleYear
Melatonin, a calpain inhibitor in the central nervous system: Current status and future perspectives.
    Journal of cellular physiology, 2019, Volume: 234, Issue:2

    Dysregulation of neuronal Ca

    Topics: Animals; Calpain; Central Nervous System; Central Nervous System Diseases; Cysteine Proteinase Inhibitors; Humans; Melatonin; Signal Transduction

2019
Development and therapeutic potential of calpain inhibitors.
    Advances in pharmacology (San Diego, Calif.), 1997, Volume: 37

    Topics: Animals; Calcium; Calpain; Cataract; Central Nervous System Diseases; Humans; Muscular Dystrophies; Myocardial Ischemia; Proteins

1997
Calpain inhibition: an overview of its therapeutic potential.
    Trends in pharmacological sciences, 1994, Volume: 15, Issue:11

    Increasing evidence now suggests that excessive activation of the Ca(2+)-dependent protease calpain could play a key or contributory role in the pathology of a variety of disorders, including cerebral ischaemia, cataract, myocardial ischaemia, muscular dystrophy and platelet aggregation. In this review, Kevin Wang and Po-Wai Yuen discuss the evidence linking these disorders to calpain overactivation. At present, it is difficult to confirm the exact role of calpain in these disorders because of the lack of potent, selective and cell-permeable calpain inhibitors. However, given the multiple therapeutic indications for calpain, it appears that achievement of selective calpain inhibition is an important pharmacological goal.

    Topics: Amino Acid Sequence; Brain Ischemia; Calpain; Central Nervous System Diseases; Humans; Molecular Sequence Data; Myocardial Ischemia

1994